Delivery Order SPE2DB24D1104-SPE2DB25FYBB2

Award Date 5/16/25
Potential Completion Date 6/9/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,352.49 Firm Fixed Price delivery order covers the supply of ERLEADA 240 MG TABLET medical products. The contract has an ultimate completion date of January 10, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $7,558.78 firm-fixed-price delivery order contract is for the supply of ERLEADA 60 MG TABLET medical products. The award is not associated with a set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,352.49 firm fixed-price delivery order is for the supply of ERLEADA 240 MG TABLET UU 30S, a medical product, with a completion date of March 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,213.74 firm-fixed-price contract is for the delivery of Erleada 240 mg tablets, a specialty medication. The contract has an ultimate completion date of August 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product. The $7,306.27 firm fixed-price delivery order has a completion date of November 8, 2024 and was awarded on October 18, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,558.78 firm fixed-price delivery order contract is for the supply of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product, to support federal government healthcare requirements. The contract has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $15,117.58, is for the delivery of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product. The contract has a completion date of January 28, 2025 and is a Firm Fixed Price Delivery Order. The award is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,704.98 firm fixed-price delivery order is for the supply of ERLEADA 240 MG TABLET, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of April 16, 2025 and was awarded on March 26, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The $7,106.87 firm fixed price delivery order is for the medication Erleada 60 mg tablet and has an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025....
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $7,306.27 firm fixed-price delivery order is for the supply of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product, with a completion date of November 6, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB25FYBB2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,117.58 firm fixed-price delivery order is for the supply of Erleada 60 mg tablets, with a completion date of June 9, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00. This IDC, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. This delivery order is not designated as a set-aside contract.

Generated 8/15/25, 9:50 AM